Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma

  • Junichi Kiyasu
    Department of Pathology, Kurume University, School of Medicine, Kurume, Japan;
  • Hiroaki Miyoshi
    Department of Pathology, Kurume University, School of Medicine, Kurume, Japan;
  • Akie Hirata
    Department of Geriatric Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan;
  • Fumiko Arakawa
    Department of Pathology, Kurume University, School of Medicine, Kurume, Japan;
  • Ayako Ichikawa
    Department of Pathology, Kurume University, School of Medicine, Kurume, Japan;
  • Daisuke Niino
    Department of Pathology, Kurume University, School of Medicine, Kurume, Japan;
  • Yasuo Sugita
    Department of Pathology, Kurume University, School of Medicine, Kurume, Japan;
  • Yuji Yufu
    Department of Hematology, Iizuka Hospital, Iizuka, Japan;
  • Ilseung Choi
    Department of Hematology, National Kyushu Cancer Center, Fukuoka, Japan;
  • Yasunobu Abe
    Department of Hematology, National Kyushu Cancer Center, Fukuoka, Japan;
  • Naokuni Uike
    Department of Hematology, National Kyushu Cancer Center, Fukuoka, Japan;
  • Koji Nagafuji
    Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan; and
  • Takashi Okamura
    Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan; and
  • Koichi Akashi
    Department of Medicine and Biosystemic Science, Kyushu University Faculty of Medicine, Fukuoka, Japan
  • Ryoichi Takayanagi
    Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan;
  • Motoaki Shiratsuchi
    Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan;
  • Koichi Ohshima
    Department of Pathology, Kurume University, School of Medicine, Kurume, Japan;

書誌事項

公開日
2015-11-05
資源種別
journal article
DOI
  • 10.1182/blood-2015-02-629600
公開者
American Society of Hematology

この論文をさがす

説明

<jats:title>Key Points</jats:title> <jats:p>PD-L1 expression is associated with poor prognosis in DLBCL. The double-staining technique is a useful method for identifying and distinguishing PD-L1+ DLBCL.</jats:p>

収録刊行物

  • Blood

    Blood 126 (19), 2193-2201, 2015-11-05

    American Society of Hematology

被引用文献 (43)*注記

もっと見る

参考文献 (38)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ